KEY FEATURES
| Full Name | Xeroderma Pigmentosum, Complementation Group C |
|---|---|
| Synonym | XP-C; XP3; XPCC; RAD4; Xeroderma Pigmentosum Group C Protein; DNA repair protein complementing XP-C cells |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.12ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human XPC in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human XPC. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human XPC and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human XPC, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human XPC. You can calculate the concentration of Human XPC in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human XPC ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.94 | 3.15 | 8.81 | 0.97 | 2.97 | 8.4 |
| Standard deviation | 0.05 | 0.14 | 0.28 | 0.06 | 0.14 | 0.33 |
| CV(%) | 5.82 | 4.52 | 3.17 | 6.22 | 4.69 | 3.96 |
RECOVERY
The recovery of Human XPC spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 91-106 | 98 |
| EDTA plasma (n=8) | 94-108 | 101 |
| Cell culture media (n=8) | 88-102 | 96 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human XPC in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with XPC ELISA Kits
| XPA ELISA Kit | publications with XPC and XPA |
| ERCC2 ELISA Kit | publications with XPC and ERCC2 |
| DDB2 ELISA Kit | publications with XPC and DDB2 |
| RAD23B ELISA Kit | publications with XPC and RAD23B |
| ERCC5 ELISA Kit | publications with XPC and ERCC5 |
| ERCC4 ELISA Kit | publications with XPC and ERCC4 |
| CETN2 ELISA Kit | publications with XPC and CETN2 |
| DDB1 ELISA Kit | publications with XPC and DDB1 |
| ERCC3 ELISA Kit | publications with XPC and ERCC3 |
| GTF2H1 ELISA Kit | publications with XPC and GTF2H1 |
Pathways associated with XPC ELISA Kit
| DNA Damage Recognition In GG-NER Pathway | DNA Damage Recognition In GG-NER Pathway |
| DNA Repair Pathway | DNA Repair Pathway |
| Dual Incision Reaction In GG-NER Pathway | Dual Incision Reaction In GG-NER Pathway |
| Formation Of Incision Complex In GG-NER Pathway | Formation Of Incision Complex In GG-NER Pathway |
| Global Genomic NER (GG-NER) Pathway | Global Genomic NER (GG-NER) Pathway |
| Nucleotide Excision Repair Pathway | Nucleotide Excision Repair Pathway |
Diseases associated with XPC ELISA Kit
| Skin Diseases | publications with XPC and Skin Diseases |
| Precancerous Conditions | publications with XPC and Precancerous Conditions |
| Lung Neoplasms | publications with XPC and Lung Neoplasms |
| Carcinoma, Squamous Cell | publications with XPC and Carcinoma, Squamous Cell |
| Nervous System Diseases | publications with XPC and Nervous System Diseases |
| Breast Neoplasms | publications with XPC and Breast Neoplasms |
| Urinary Bladder Neoplasms | publications with XPC and Urinary Bladder Neoplasms |
| Neoplasms, Experimental | publications with XPC and Neoplasms, Experimental |
| Chromosome Aberrations | publications with XPC and Chromosome Aberrations |
| Cell Transformation, Neoplastic | publications with XPC and Cell Transformation, Neoplastic |
Organs/Tissues associated with XPC ELISA Kit
| Skin | publications with XPC and Skin |
| Lung | publications with XPC and Lung |
| Blood | publications with XPC and Blood |
| Bladder | publications with XPC and Bladder |
| Liver | publications with XPC and Liver |
| Prostate | publications with XPC and Prostate |
| Bone | publications with XPC and Bone |
| Brain | publications with XPC and Brain |
| Stomach | publications with XPC and Stomach |
| Testis | publications with XPC and Testis |